SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000950170-24-031541
Filing Date
2024-03-14
Accepted
2024-03-14 16:33:36
Documents
5
Effectiveness Date
2024-03-14

Document Format Files

Seq Description Document Type Size
1 S-8 2024_form_s-8.htm S-8 108259
2 EX-5.1 kzr-ex5_1.htm EX-5.1 13759
3 EX-23.1 kzr-ex23_1.htm EX-23.1 2625
4 EX-FILING FEES kzr-exfiling_fees.htm EX-FILING FEES 23280
5 GRAPHIC img55147677_0.jpg GRAPHIC 29364
  Complete submission text file 0000950170-24-031541.txt   189556
Mailing Address 4000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 4000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-822-5600
Kezar Life Sciences, Inc. (Filer) CIK: 0001645666 (see all company filings)

IRS No.: 473366145 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-277939 | Film No.: 24750735
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)